Anti-Apolipoprotein (a) Antibody Biotinylated

<strong>Anti-Apolipoprotein(a) Antibody Biotinylated</strong>_x000D_ <strong>Catalog number:</strong> B2012781_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 501.3 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Anti-Apolipoprotein(a) Antibody, clone LPA4 Antibody, Biotin Conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Radwan MM, El-Lebedy D, Fouda R, Elsorougy E. Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus Clin Rheumatol. 2014 Apr;33(4):493-8._x000D_ 2: L'Huillier AG, Pagano S, Baggio S, Meyer B, Andrey DO, Nehme M, Guessous I, Eberhardt CS, Huttner A, Posfay-Barbe KM, Yerly S, Siegrist CA, Kaiser L, Vuilleumier N. Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence Eur J Clin Invest. 2022 Oct;52(10):e13818._x000D_ 3: Adam S, Ho JH, Liu Y, Siahmansur T, Iqbal Z, Pagano S, Azmi S, Dhage SS, Donn R, Ammori BJ, Syed AA, Durrington PN, Malik RA, Vuilleumier N, Soran H. Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort Study Obes Surg. 2022 Feb;32(2):355-364._x000D_ 4: Rudewicz-Kowalczyk D, Grabowska I. Antibody-Ferrocene Conjugates as a Platform for Electro-Chemical Detection of Low-Density Lipoprotein Molecules. 2022 Aug 26;27(17):5492._x000D_ 5: Pagano S, Yerly S, Meyer B, Juillard C, Suh N, Le Terrier C, Daguer JP, Farrera-Soler L, Barluenga S, Piumatti G, Hartley O, Lemaitre B, Eberhardt CS, Siegrist CA, Eckerle I, Stringhini S, Guessous I, Kaiser L, Pugin J, Winssinger N, Vuilleumier N. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 Eur J Clin Invest. 2021 Nov;51(11):e13661._x000D_ 6: Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction Eur Heart J. 2010 Apr;31(7):815-23._x000D_ 7: Montecucco F, Vuilleumier N, Pagano S, Lenglet S, Bertolotto M, Braunersreuther V, Pelli G, Kovari E, Pane B, Spinella G, Pende A, Palombo D, Dallegri F, Mach F, Roux-Lombard P. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability Eur Heart J. 2011 Feb;32(4):412-21._x000D_ 8: Teixeira PC, Cutler P, Vuilleumier N. Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives Clin Dev Immunol. 2012;2012:868251._x000D_ 9: da Silva RF, Baptista D, Roth A, Miteva K, Burger F, Vuilleumier N, Carbone F, Montecucco F, Mach F, Brandt KJ. Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques Int J Mol Sci. 2020 Oct 19;21(20):7721._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/25890187">10: Croca S, Bassett P, Chambers S, Davari M, Alber KF, Leach O, Ioannou Y, Giles I, Isenberg D, Rahman A. IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study Arthritis Res Ther. 2015 Feb 9;17(1):26. </a>_x000D_ _x000D_ <strong>Products Related to Anti-Apolipoprotein(a) Antibody Biotinylated can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>